Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry

Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry

Registry for patients undergoing pacemaker/ICD implantation including a transtricuspid lead with and without intraprocedural transesophageal echocardiography to evaluate risk factors for lead induced tricuspid regurgitation.

Lead induced tricuspid regurgitation is a common finding after pacemaker/ICD Implantation. Transesophageal echocardiography (TEE) might be used to guide lead implantations in order to prevent tricuspid regurgitation.

In this registry, patients undergoing pacemaker/ICD implantation including a transtricuspid lead are enrolled. While in most patients lead implantation is guided by fluroscopy, in some patients lead implantation is guided by TEE in addition to fluroscopy.

Aims of this registry: Evaluation of

• Incidence of lead induced tricuspid regurgitation
• Mortality and morbidity of lead induced tricuspid regurgitation
• Identification of risk factors for lead induced tricuspid regurgitation
• Influence of the lead position within the tricuspid valve on the incidence of lead induced tricuspid regurgitation
• Prevention of lead induced tricuspid regurgitation by TEE-guided lead implantation

Inclusion Criteria:

• indication for pacemaker/ICD implantation including a transtricuspid lead according to guidelines

Exclusion Criteria:

• pre-existing RV lead
• pre-existing TR >2